{
"id":"mk19_b_rm_t16",
"number":16,
"bookId":"rm",
"title":{
"__html":"Comparison of ACR Diagnostic Criteria and ACTTION-APS Pain Taxonomy Diagnostic Criteria for Fibromyalgia<sup>a</sup>"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"d841d6",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 16. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_rm_t16"
}
]
},
"Comparison of ACR Diagnostic Criteria and ACTTION-APS Pain Taxonomy Diagnostic Criteria for Fibromyalgia",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0e71e",
"class":"col hd l",
"children":[
"2010 ACR Preliminary Diagnostic Criteria (2016 Revision)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72b76a",
"class":"col hd l",
"children":[
"ACTTION-APS Pain Taxonomy Criteria (2019)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4a4ff9",
"class":"cell txt l",
"children":[
"Widespread pain by Widespread Pain Index (19-point scale) assessing number of regions in which patient has pain",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b,c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"56dc04",
"class":"cell txt l",
"children":[
"Musculoskeletal pain defined as ≥6 pain sites from total of 9 possible sites"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7e4711",
"class":"cell txt l",
"children":[
"Symptom severity by Symptom Severity Scale (12-point scale) assessing fatigue, nonrestorative sleep, and cognitive symptoms",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b,c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c1fc0c",
"class":"cell txt l",
"children":[
"Moderate to severe sleep problems ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" fatigue"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5e20a",
"class":"cell txt l",
"children":[
"Duration of symptoms ≥3 months"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0f029c",
"class":"cell txt l",
"children":[
"Musculoskeletal pain plus fatigue or sleep problems must have been present for ≥3 months"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"11dab0",
"class":"cell txt l",
"children":[
"No other disorder explaining the pain"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ACR = American College of Rheumatology; ACTTION = Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks; APS = American Pain Society."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"A diagnosis of fibromyalgia does not exclude the presence of other clinically important illnesses."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Fibromyalgia is diagnosed in the setting of Widespread Pain Index ≥7 plus Symptom Severity Scale score ≥5, or Widespread Pain Index ≥3 plus Symptom Severity Scale score ≥9."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Widespread Pain Index and Symptom Severity Scale can be viewed at ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.rheumatology.org/Portals/0/Files/2010%20Fibromyalgia%20Diagnostic%20Criteria_Excerpt.pdf",
"target":"_blank"
},
"children":[
"https://www.rheumatology.org/Portals/0/Files/2010%20Fibromyalgia%20Diagnostic%20Criteria_Excerpt.pdf"
]
},
"."
]
]
}